Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
An Investigation of the Role of Germ-Line Mutations in Cancer Predisposition, Tumor Biology, and Response to Treatment
Jonsson Comprehensive Cancer Center
2,000 participants
Sep 16, 2014
OBSERVATIONAL
Conditions
Summary
This research trial studies germ-line mutations in blood and saliva samples from patients with cancer. Studying samples of blood and saliva from patients with cancer in the laboratory may help doctors learn more about how inherited genetic mutations can affect cancer predisposition (an inherited increase in the risk of developing cancer), their impact on treatment response, and their role in cancer development.
Eligibility
Inclusion Criteria2
- Pathologically or clinical confirmed tissue diagnosis of a cancer
- Ability to understand and the willingness to sign a written informed consent
Exclusion Criteria2
- Patients will be excluded if their cancer cannot be confirmed
- Refusal to sign the informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Correlative studies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02280161